The maker of the ADHD drug Vyvanse has been given approval by the US Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues. HealthDay News — The ...

Higher doses of commonly prescribed ADHD medications may increase the risk of psychosis, a new study has found Getty High doses of commonly prescribed medications for ADHD have been linked to an ...

WASHINGTON — The Drug Enforcement Administration has increased the production limit for the ADHD drug Vyvanse and its generic versions to combat the medicine's ongoing shortage, according to a notice ...

Elite received approval from the Food and Drug Administration for a generic version of Vyvanse (lisdexamfetamine dimesylate) capsules in strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg ...

WILMINGTON, Del.--(BUSINESS WIRE)--Noramco, LLC, a leading North American producer of controlled substance bulk Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, today ...

Elite has launched Elite's a generic version of Vyvanse (lisdexamfetamine disylate) in dosage strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg capsules. Generic Vyvanse is indicated for ...

Feb 6 (Reuters) - Shire Plc's Vyvanse, a top-selling medicine for hyperactivity, failed in two late-stage clinical trials to successfully treat adults with major depressive disorders, the ...

Several lots of a generic ADHD medication used by millions are under recall because users may not be getting the full benefit. Sun Pharmaceutical Industries issued the voluntary, nationwide recall for ...

Leading Producer of Controlled Substance APIs Now Supplying Lisdex API to Generic Drug Manufacturers Preparing for the 2023 Patent Expiry of Top-Selling Branded ADHD Therapy WILMINGTON, ...